Unknown

Dataset Information

0

Evaluating the Impact of CYP2D6 Phenotype on Fluvoxamine Pharmacokinetics in Geriatric Patients Using Physiologically Based Pharmacokinetic Modeling

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC12944153 | biostudies-literature | 2026 Feb

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Predicting Resolvin D1 Pharmacokinetics in Humans with Physiologically-Based Pharmacokinetic Modeling.
| S-EPMC7993257 | biostudies-literature
Unknown Application of physiologically-based pharmacokinetic modeling to inform dosing decisions for geriatric patients.
| S-EPMC11646931 | biostudies-literature
Unknown Physiologically-based pharmacokinetic modeling of dextromethorphan to investigate interindividual variability within CYP2D6 activity score groups.
| S-EPMC9007601 | biostudies-literature
Unknown Physiologically based pharmacokinetic modeling to predict the effect of risperidone on aripiprazole pharmacokinetics in subjects with different CYP2D6 genotypes and individuals with hepatic impairment.
| S-EPMC11656427 | biostudies-literature
Unknown Prediction of CYP-Mediated Drug Interaction Using Physiologically Based Pharmacokinetic Modeling: A Case Study of Salbutamol and Fluvoxamine.
| S-EPMC10301358 | biostudies-literature
Unknown Physiologically based pharmacokinetic (PBPK) modeling of the role of CYP2D6 polymorphism for metabolic phenotyping with dextromethorphan.
| S-EPMC9637881 | biostudies-literature
Unknown Physiologically Based Pharmacokinetic Modeling of Metoprolol Enantiomers and α-Hydroxymetoprolol to Describe CYP2D6 Drug-Gene Interactions.
| S-EPMC7763912 | biostudies-literature
Unknown Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach.
| S-EPMC8613074 | biostudies-literature
Unknown Application of Physiologically Based Pharmacokinetic Modeling to Predict Pharmacokinetics in Healthy Japanese Subjects.
| S-EPMC6587435 | biostudies-literature
Unknown Potential and challenges in application of physiologically based pharmacokinetic modeling in predicting diarrheal disease impact on oral drug pharmacokinetics.
| S-EPMC12698036 | biostudies-literature